Skip to main content

Amneal Pharmaceuticals, Inc.

AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001723128

In the last 90 days, Amneal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.82B in total; no superinvestor holds it.

13F holders, Q4 2025

Institutional positions in Amneal Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
278
+33 vs. Q3 2025
Shares held
154.6M
+3.90M (+2.6%) vs. Q3 2025
Total value
$1.95B
+$439.0M (+29.1%) vs. Q3 2025
New holders
57
101 more added
Sold out
24
80 more reduced

3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AMRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 278 institutions
Q1 2021: 161 institutionsQ2 2021: 160 institutionsQ3 2021: 155 institutionsQ4 2021: 154 institutionsQ1 2022: 168 institutionsQ2 2022: 153 institutionsQ3 2022: 155 institutionsQ4 2022: 157 institutionsQ1 2023: 145 institutionsQ2 2023: 128 institutionsQ3 2023: 144 institutionsQ4 2023: 153 institutionsQ1 2024: 176 institutionsQ2 2024: 182 institutionsQ3 2024: 183 institutionsQ4 2024: 200 institutionsQ1 2025: 238 institutionsQ2 2025: 241 institutionsQ3 2025: 248 institutionsQ4 2025: 278 institutionsQ1 2026: 317 institutionsQ2 2026: 311 institutions
Value heldQ4 2025: $1.95B
Q1 2021: $683.6MQ2 2021: $511.6MQ3 2021: $535.3MQ4 2021: $481.1MQ1 2022: $417.2MQ2 2022: $316.0MQ3 2022: $201.0MQ4 2022: $202.7MQ1 2023: $134.7MQ2 2023: $302.0MQ3 2023: $430.0MQ4 2023: $663.1MQ1 2024: $655.2MQ2 2024: $880.5MQ3 2024: $1.19BQ4 2024: $998.7MQ1 2025: $1.14BQ2 2025: $1.16BQ3 2025: $1.51BQ4 2025: $1.95BQ1 2026: $2.00BQ2 2026: $2.82B
Institutions holding AMRX and their total value by quarter
QuarterHoldersValue
Q2 2026311$2.82B
Q1 2026317$2.00B
Q4 2025278$1.95B
Q3 2025248$1.51B
Q2 2025241$1.16B
Q1 2025238$1.14B
Q4 2024200$998.7M
Q3 2024183$1.19B
Q2 2024182$880.5M
Q1 2024176$655.2M
Q4 2023153$663.1M
Q3 2023144$430.0M
Q2 2023128$302.0M
Q1 2023145$134.7M
Q4 2022157$202.7M
Q3 2022155$201.0M
Q2 2022153$316.0M
Q1 2022168$417.2M
Q4 2021154$481.1M
Q3 2021155$535.3M
Q2 2021160$511.6M
Q1 2021161$683.6M

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Amneal Pharmaceuticals, Inc.; share changes are against Q3 2025.

Institutions holding AMRX in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Cloud Capital Management, LLC0$00.00%−16−100.0%Sold out
Colony Group, LLC0$00.00%−4,203−100.0%Sold out
Vishria Bird Financial Group, LLC––––Not filed
CIBC Bancorp USA Inc.––––Not filed
Hemington Wealth Management––––Not filed